Renaissance Technologies’s BioVie BIVI Stock Holding History

Renaissance Technologies’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$248K	Buy	127,918 +60,000	+88%	+$94.2K	﹤0.01%	2830
2026 Q1	$95.1K	Buy	67,918 +39,900	+142%	+$51.3K	﹤0.01%	3037
2025 Q4	$32.5K	Sell	28,018 -44,900	-62%	-$72.3K	﹤0.01%	3115
2025 Q3	$139K	Buy	+72,918	New	+$295K	﹤0.01%	3210
2024 Q2	–	Sell	-3,474	Closed	-$184K	–	3508
2024 Q1	$184K	Buy	+3,474	New	+$356K	﹤0.01%	3246
2023 Q1	–	Sell	-2,973	Closed	-$2.31M	–	3983
2022 Q4	$2.31M	Buy	2,973 +2,738	+1,165%	+$1.48M	﹤0.01%	1989
2022 Q3	$59K	Buy	235 +75	+47%	+$17.8K	﹤0.01%	3710
2022 Q2	$23K	Buy	+160	New	+$48K	﹤0.01%	4104
2021 Q4	–	Sell	-531	Closed	-$355K	–	3900
2021 Q3	$355K	Buy	531 +252	+90%	+$270K	﹤0.01%	3024
2021 Q2	$473K	Buy	+279	New	+$434K	﹤0.01%	2984

Other funds holding BIVI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PTC

Philadelphia Trust Company Philadelphia, Pennsylvania $1.56B AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.37B AUM 71.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Renaissance Technologies's BIVI Position: Q2 2026 in Review

Renaissance Technologies increased its BioVie (BIVI) stake by 88% in Q2 2026, buying an estimated $94.2K and bringing the position to 127,918 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #2830.

Renaissance Technologies first reported a position in BIVI in Q2 2021 and has held it in 10 quarters since. The position peaked at $2.31M in Q4 2022. 36 funds tracked by Wall St. Rank hold BIVI as of Q2 2026.

Renaissance Technologies held 127,918 shares of BioVie worth $248K as of Q2 2026.
Renaissance Technologies bought 60,000 BioVie shares in Q2 2026, an estimated $94.2K.
BioVie made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2830 holding.
Renaissance Technologies first reported a position in BioVie in Q2 2021 and has held it in 10 quarters since.
Renaissance Technologies's BioVie position peaked at $2.31M in Q4 2022.
36 funds tracked by Wall St. Rank held BioVie as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.